SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
SOLIGENIX, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.34−0.01 (-2.66%)
Close on Oct 19, 2026
- Market cap
- $5.48M
- P/E (TTM)
- –
- Dividend yield
- –
Soligenix statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Soligenix | Industry median |
|---|---|---|
| Market Cap | $7.48M | $197.05M |
| Enterprise Value | -$2.33M | $106.56M |
| PB Ratio | 1.13 | 2.14 |
| P/TBV Ratio | 1.13 | 2.46 |
Income (trailing twelve months)
| Measure | Soligenix | Industry median |
|---|---|---|
| Operating Income | -$11.04M | -$21.44M |
| Pretax Income | -$10.75M | -$14.45M |
| Net Income | -$10.24M | -$22.46M |
| EBITDA | -$11.04M | -$16.91M |
Returns
| Measure | Soligenix | Industry median |
|---|---|---|
| Return on Equity (ROE) | -241.7% | -53.1% |
| Return on Assets (ROA) | -125.9% | -41.0% |
| Return on Capital Employed (ROCE) | -161.7% | -37.8% |
Balance sheet
| Measure | Soligenix | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.81M | $62.42M |
| Net Cash (Debt) | $9.81M | $15.68M |
| Net Cash Per Share | $0.45 | $0.65 |
| Equity (Book Value) | $6.65M | $48.79M |
| Book Value Per Share | $0.31 | $1.36 |
| Tangible Book Value | $6.65M | $23.06M |
| Working Capital | $6.50M | $75.77M |
Financial position
| Measure | Soligenix | Industry median |
|---|---|---|
| Current Ratio | 2.77 | 3.30 |
| Quick Ratio | 2.67 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Soligenix | Industry median |
|---|---|---|
| Operating Cash Flow | -$9.74M | -$12.35M |
Efficiency
| Measure | Soligenix | Industry median |
|---|---|---|
| Profits Per Employee | -$731.39K | -$732.08K |
| Employee Count | 14 | 73 |
Dividends and yields
| Measure | Soligenix | Industry median |
|---|---|---|
| Earnings Yield | -136.9% | -21.2% |
Shares
| Measure | Soligenix | Industry median |
|---|---|---|
| Shares Outstanding | 21,765,500 | 59,128,900 |
| Shares Change (YoY) | 267.0% | 11.1% |
| Shares Change (QoQ) | 105.7% | 0.54% |
| Float | 21,614,900 | 48,744,500 |
| Shares Held by Insiders | 0.69% | 11.8% |
| Shares Held by Institutions | 4.29% | 59.4% |
Scores
| Measure | Soligenix | Industry median |
|---|---|---|
| Altman Z-Score | -34.88 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Soligenix's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.